Cargando…
The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model
PURPOSE: To evaluate the use of subconjunctival bevacizumab on corneal neovascularization in an experimental rabbit model for its effect on vessel extension, inflammation, and corneal epithelialization. METHODS: In this prospective, randomized, blinded, experimental study, 20 rabbits were submitted...
Autores principales: | Mello, Glauco Reggiani, Pizzolatti, Marcos Longo, Wasilewski, Daniel, Santhiago, Marcony R., Budel, Vinícius, Moreira, Hamilton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161226/ https://www.ncbi.nlm.nih.gov/pubmed/21915498 http://dx.doi.org/10.1590/S1807-59322011000800023 |
Ejemplares similares
-
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
por: Britton, Anna Krystyna, et al.
Publicado: (2020) -
The Effect of Bevacizumab on Corneal Neovascularization in Rabbits
por: Kim, Wung-Jae, et al.
Publicado: (2010) -
Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats
por: Hashemian, Mohammad Nasser, et al.
Publicado: (2017) -
Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns
por: Peng, Wen-yan, et al.
Publicado: (2023) -
Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab
por: Ryoo, Na Kyung, et al.
Publicado: (2013)